- Home
- INTS vs PODC Comparison
INTS vs PODC Comparison
Compare INTS & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- PODC
- Stock Information
- Founded
- INTS 2012
- PODC 2013
- Country
- INTS United States
- PODC United States
- Employees
- INTS N/A
- PODC N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- PODC
- Sector
- INTS Health Care
- PODC
- Exchange
- INTS Nasdaq
- PODC Nasdaq
- Market Cap
- INTS 8.0M
- PODC 44.1M
- IPO Year
- INTS 2023
- PODC N/A
- Fundamental
- Price
- INTS $0.33
- PODC $2.18
- Analyst Decision
- INTS Strong Buy
- PODC
- Analyst Count
- INTS 3
- PODC 0
- Target Price
- INTS $8.50
- PODC N/A
- AVG Volume (30 Days)
- INTS 3.7M
- PODC 115.7K
- Earning Date
- INTS 08-07-2025
- PODC 08-12-2025
- Dividend Yield
- INTS N/A
- PODC N/A
- EPS Growth
- INTS N/A
- PODC N/A
- EPS
- INTS N/A
- PODC N/A
- Revenue
- INTS N/A
- PODC $52,119,000.00
- Revenue This Year
- INTS N/A
- PODC $19.39
- Revenue Next Year
- INTS N/A
- PODC $23.41
- P/E Ratio
- INTS N/A
- PODC N/A
- Revenue Growth
- INTS N/A
- PODC 20.36
- 52 Week Low
- INTS $0.26
- PODC $1.10
- 52 Week High
- INTS $5.10
- PODC $2.94
- Technical
- Relative Strength Index (RSI)
- INTS 41.29
- PODC 49.55
- Support Level
- INTS $0.26
- PODC $2.01
- Resistance Level
- INTS $0.32
- PODC $2.94
- Average True Range (ATR)
- INTS 0.03
- PODC 0.35
- MACD
- INTS 0.02
- PODC -0.03
- Stochastic Oscillator
- INTS 62.56
- PODC 31.47
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.